International Journal of Biological Sciences-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2117981, encodeId=f6a1211e981d8, content=2.8号投稿，审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Mon Mar 06 19:49:41 CST 2023, time=2023-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229420, encodeId=75dc1229420c9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：非编码RNA;上皮间质转化 经验分享：刚刚被拒。投稿3天后就送审了，还是周末状态改变的（按大家的经验应该是replace消失代表送审），等了刚好1个月的时候被拒的。理由是没找到审稿人，没有看到审稿人的意见。整体感觉编辑反应迅速的，可能IF涨了之后要求也高了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1ab5535030, createdName=简单93, createdTime=Wed Jun 29 11:17:57 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196851, encodeId=086c1196851a5, content=已经被预警了…现在在投的要撤稿吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJoHgeANyXDE4pHH8hREKNANRqlQhT0H9NBxJdM9icDDaq26HzcfpPWKn9wujOibbibULY65yuG4RWLg/132, createdBy=7b682217847, createdName=120f0027m97(暂无昵称), createdTime=Thu Feb 24 15:56:46 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090098, encodeId=56e62090098ac, content=请问这种情况Received 2022-9-23 from IP This manuscript is under review.但是replace没有消失的话是不是稿子还在编辑那儿没有送审啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14186510067, createdName=ms9000000493647933, createdTime=Sat Sep 24 11:45:31 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226665, encodeId=f04112266653b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础;肠道菌群 经验分享：发表一个月了，Web of science 核心数据库还检索不到，但是同卷的有的文章能检索到了，这是杂志问题还是Web of science库问题呀，开不了收录证明，好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99ea5615441, createdName=我们都是小白鼠, createdTime=Wed Jun 15 21:31:09 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205182, encodeId=a2961205182a4, content=Manuscript file和Cover letter文件后面的“replace”消失， Stats状态栏显示的是（active），然后显示的是Received 2022-3-9 from IP *.*.*.* This manuscript is under review. 请问这个状态代表的是已经送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed Mar 23 11:04:10 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996961, encodeId=ab889969615f, content=看这个杂志国人发文量差不多百分之九十，同一出版社的姊妹期刊有被预警的，想问下这个杂志质量怎么样，以后会不会被预警啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Jul 07 00:00:28 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111773, encodeId=15ea2111e73f5, content=偏重的研究方向：肿瘤 经验分享：2023.1.27 正月初六 submit , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Sat Jan 28 01:22:55 CST 2023, time=2023-01-28, status=1, ipAttribution=天津)]

2023-03-06 541350208 来自重庆

2.8号投稿，审稿中

33 19

展开19条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117981, encodeId=f6a1211e981d8, content=2.8号投稿，审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Mon Mar 06 19:49:41 CST 2023, time=2023-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229420, encodeId=75dc1229420c9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：非编码RNA;上皮间质转化 经验分享：刚刚被拒。投稿3天后就送审了，还是周末状态改变的（按大家的经验应该是replace消失代表送审），等了刚好1个月的时候被拒的。理由是没找到审稿人，没有看到审稿人的意见。整体感觉编辑反应迅速的，可能IF涨了之后要求也高了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1ab5535030, createdName=简单93, createdTime=Wed Jun 29 11:17:57 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196851, encodeId=086c1196851a5, content=已经被预警了…现在在投的要撤稿吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJoHgeANyXDE4pHH8hREKNANRqlQhT0H9NBxJdM9icDDaq26HzcfpPWKn9wujOibbibULY65yuG4RWLg/132, createdBy=7b682217847, createdName=120f0027m97(暂无昵称), createdTime=Thu Feb 24 15:56:46 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090098, encodeId=56e62090098ac, content=请问这种情况Received 2022-9-23 from IP This manuscript is under review.但是replace没有消失的话是不是稿子还在编辑那儿没有送审啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14186510067, createdName=ms9000000493647933, createdTime=Sat Sep 24 11:45:31 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226665, encodeId=f04112266653b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础;肠道菌群 经验分享：发表一个月了，Web of science 核心数据库还检索不到，但是同卷的有的文章能检索到了，这是杂志问题还是Web of science库问题呀，开不了收录证明，好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99ea5615441, createdName=我们都是小白鼠, createdTime=Wed Jun 15 21:31:09 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205182, encodeId=a2961205182a4, content=Manuscript file和Cover letter文件后面的“replace”消失， Stats状态栏显示的是（active），然后显示的是Received 2022-3-9 from IP *.*.*.* This manuscript is under review. 请问这个状态代表的是已经送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed Mar 23 11:04:10 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996961, encodeId=ab889969615f, content=看这个杂志国人发文量差不多百分之九十，同一出版社的姊妹期刊有被预警的，想问下这个杂志质量怎么样，以后会不会被预警啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Jul 07 00:00:28 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111773, encodeId=15ea2111e73f5, content=偏重的研究方向：肿瘤 经验分享：2023.1.27 正月初六 submit , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Sat Jan 28 01:22:55 CST 2023, time=2023-01-28, status=1, ipAttribution=天津)]

2022-06-29 简单93

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：非编码RNA;上皮间质转化
经验分享：刚刚被拒。投稿3天后就送审了，还是周末状态改变的（按大家的经验应该是replace消失代表送审），等了刚好1个月的时候被拒的。理由是没找到审稿人，没有看到审稿人的意见。整体感觉编辑反应迅速的，可能IF涨了之后要求也高了吧。

49 18

展开18条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117981, encodeId=f6a1211e981d8, content=2.8号投稿，审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Mon Mar 06 19:49:41 CST 2023, time=2023-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229420, encodeId=75dc1229420c9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：非编码RNA;上皮间质转化 经验分享：刚刚被拒。投稿3天后就送审了，还是周末状态改变的（按大家的经验应该是replace消失代表送审），等了刚好1个月的时候被拒的。理由是没找到审稿人，没有看到审稿人的意见。整体感觉编辑反应迅速的，可能IF涨了之后要求也高了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1ab5535030, createdName=简单93, createdTime=Wed Jun 29 11:17:57 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196851, encodeId=086c1196851a5, content=已经被预警了…现在在投的要撤稿吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJoHgeANyXDE4pHH8hREKNANRqlQhT0H9NBxJdM9icDDaq26HzcfpPWKn9wujOibbibULY65yuG4RWLg/132, createdBy=7b682217847, createdName=120f0027m97(暂无昵称), createdTime=Thu Feb 24 15:56:46 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090098, encodeId=56e62090098ac, content=请问这种情况Received 2022-9-23 from IP This manuscript is under review.但是replace没有消失的话是不是稿子还在编辑那儿没有送审啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14186510067, createdName=ms9000000493647933, createdTime=Sat Sep 24 11:45:31 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226665, encodeId=f04112266653b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础;肠道菌群 经验分享：发表一个月了，Web of science 核心数据库还检索不到，但是同卷的有的文章能检索到了，这是杂志问题还是Web of science库问题呀，开不了收录证明，好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99ea5615441, createdName=我们都是小白鼠, createdTime=Wed Jun 15 21:31:09 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205182, encodeId=a2961205182a4, content=Manuscript file和Cover letter文件后面的“replace”消失， Stats状态栏显示的是（active），然后显示的是Received 2022-3-9 from IP *.*.*.* This manuscript is under review. 请问这个状态代表的是已经送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed Mar 23 11:04:10 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996961, encodeId=ab889969615f, content=看这个杂志国人发文量差不多百分之九十，同一出版社的姊妹期刊有被预警的，想问下这个杂志质量怎么样，以后会不会被预警啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Jul 07 00:00:28 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111773, encodeId=15ea2111e73f5, content=偏重的研究方向：肿瘤 经验分享：2023.1.27 正月初六 submit , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Sat Jan 28 01:22:55 CST 2023, time=2023-01-28, status=1, ipAttribution=天津)]

2022-02-24 120f0027m97(暂无昵称)

已经被预警了…现在在投的要撤稿吗😭

44 18

展开18条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117981, encodeId=f6a1211e981d8, content=2.8号投稿，审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Mon Mar 06 19:49:41 CST 2023, time=2023-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229420, encodeId=75dc1229420c9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：非编码RNA;上皮间质转化 经验分享：刚刚被拒。投稿3天后就送审了，还是周末状态改变的（按大家的经验应该是replace消失代表送审），等了刚好1个月的时候被拒的。理由是没找到审稿人，没有看到审稿人的意见。整体感觉编辑反应迅速的，可能IF涨了之后要求也高了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1ab5535030, createdName=简单93, createdTime=Wed Jun 29 11:17:57 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196851, encodeId=086c1196851a5, content=已经被预警了…现在在投的要撤稿吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJoHgeANyXDE4pHH8hREKNANRqlQhT0H9NBxJdM9icDDaq26HzcfpPWKn9wujOibbibULY65yuG4RWLg/132, createdBy=7b682217847, createdName=120f0027m97(暂无昵称), createdTime=Thu Feb 24 15:56:46 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090098, encodeId=56e62090098ac, content=请问这种情况Received 2022-9-23 from IP This manuscript is under review.但是replace没有消失的话是不是稿子还在编辑那儿没有送审啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14186510067, createdName=ms9000000493647933, createdTime=Sat Sep 24 11:45:31 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226665, encodeId=f04112266653b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础;肠道菌群 经验分享：发表一个月了，Web of science 核心数据库还检索不到，但是同卷的有的文章能检索到了，这是杂志问题还是Web of science库问题呀，开不了收录证明，好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99ea5615441, createdName=我们都是小白鼠, createdTime=Wed Jun 15 21:31:09 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205182, encodeId=a2961205182a4, content=Manuscript file和Cover letter文件后面的“replace”消失， Stats状态栏显示的是（active），然后显示的是Received 2022-3-9 from IP *.*.*.* This manuscript is under review. 请问这个状态代表的是已经送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed Mar 23 11:04:10 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996961, encodeId=ab889969615f, content=看这个杂志国人发文量差不多百分之九十，同一出版社的姊妹期刊有被预警的，想问下这个杂志质量怎么样，以后会不会被预警啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Jul 07 00:00:28 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111773, encodeId=15ea2111e73f5, content=偏重的研究方向：肿瘤 经验分享：2023.1.27 正月初六 submit , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Sat Jan 28 01:22:55 CST 2023, time=2023-01-28, status=1, ipAttribution=天津)]

2022-09-24 ms9000000493647933

请问这种情况Received 2022-9-23 from IP This manuscript is under review.但是replace没有消失的话是不是稿子还在编辑那儿没有送审啊？

47 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117981, encodeId=f6a1211e981d8, content=2.8号投稿，审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Mon Mar 06 19:49:41 CST 2023, time=2023-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229420, encodeId=75dc1229420c9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：非编码RNA;上皮间质转化 经验分享：刚刚被拒。投稿3天后就送审了，还是周末状态改变的（按大家的经验应该是replace消失代表送审），等了刚好1个月的时候被拒的。理由是没找到审稿人，没有看到审稿人的意见。整体感觉编辑反应迅速的，可能IF涨了之后要求也高了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1ab5535030, createdName=简单93, createdTime=Wed Jun 29 11:17:57 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196851, encodeId=086c1196851a5, content=已经被预警了…现在在投的要撤稿吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJoHgeANyXDE4pHH8hREKNANRqlQhT0H9NBxJdM9icDDaq26HzcfpPWKn9wujOibbibULY65yuG4RWLg/132, createdBy=7b682217847, createdName=120f0027m97(暂无昵称), createdTime=Thu Feb 24 15:56:46 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090098, encodeId=56e62090098ac, content=请问这种情况Received 2022-9-23 from IP This manuscript is under review.但是replace没有消失的话是不是稿子还在编辑那儿没有送审啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14186510067, createdName=ms9000000493647933, createdTime=Sat Sep 24 11:45:31 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226665, encodeId=f04112266653b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础;肠道菌群 经验分享：发表一个月了，Web of science 核心数据库还检索不到，但是同卷的有的文章能检索到了，这是杂志问题还是Web of science库问题呀，开不了收录证明，好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99ea5615441, createdName=我们都是小白鼠, createdTime=Wed Jun 15 21:31:09 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205182, encodeId=a2961205182a4, content=Manuscript file和Cover letter文件后面的“replace”消失， Stats状态栏显示的是（active），然后显示的是Received 2022-3-9 from IP *.*.*.* This manuscript is under review. 请问这个状态代表的是已经送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed Mar 23 11:04:10 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996961, encodeId=ab889969615f, content=看这个杂志国人发文量差不多百分之九十，同一出版社的姊妹期刊有被预警的，想问下这个杂志质量怎么样，以后会不会被预警啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Jul 07 00:00:28 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111773, encodeId=15ea2111e73f5, content=偏重的研究方向：肿瘤 经验分享：2023.1.27 正月初六 submit , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Sat Jan 28 01:22:55 CST 2023, time=2023-01-28, status=1, ipAttribution=天津)]

2022-06-15 我们都是小白鼠

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：基础;肠道菌群
经验分享：发表一个月了，Web of science 核心数据库还检索不到，但是同卷的有的文章能检索到了，这是杂志问题还是Web of science库问题呀，开不了收录证明，好着急。

58 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117981, encodeId=f6a1211e981d8, content=2.8号投稿，审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Mon Mar 06 19:49:41 CST 2023, time=2023-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229420, encodeId=75dc1229420c9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：非编码RNA;上皮间质转化 经验分享：刚刚被拒。投稿3天后就送审了，还是周末状态改变的（按大家的经验应该是replace消失代表送审），等了刚好1个月的时候被拒的。理由是没找到审稿人，没有看到审稿人的意见。整体感觉编辑反应迅速的，可能IF涨了之后要求也高了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1ab5535030, createdName=简单93, createdTime=Wed Jun 29 11:17:57 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196851, encodeId=086c1196851a5, content=已经被预警了…现在在投的要撤稿吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJoHgeANyXDE4pHH8hREKNANRqlQhT0H9NBxJdM9icDDaq26HzcfpPWKn9wujOibbibULY65yuG4RWLg/132, createdBy=7b682217847, createdName=120f0027m97(暂无昵称), createdTime=Thu Feb 24 15:56:46 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090098, encodeId=56e62090098ac, content=请问这种情况Received 2022-9-23 from IP This manuscript is under review.但是replace没有消失的话是不是稿子还在编辑那儿没有送审啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14186510067, createdName=ms9000000493647933, createdTime=Sat Sep 24 11:45:31 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226665, encodeId=f04112266653b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础;肠道菌群 经验分享：发表一个月了，Web of science 核心数据库还检索不到，但是同卷的有的文章能检索到了，这是杂志问题还是Web of science库问题呀，开不了收录证明，好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99ea5615441, createdName=我们都是小白鼠, createdTime=Wed Jun 15 21:31:09 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205182, encodeId=a2961205182a4, content=Manuscript file和Cover letter文件后面的“replace”消失， Stats状态栏显示的是（active），然后显示的是Received 2022-3-9 from IP *.*.*.* This manuscript is under review. 请问这个状态代表的是已经送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed Mar 23 11:04:10 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996961, encodeId=ab889969615f, content=看这个杂志国人发文量差不多百分之九十，同一出版社的姊妹期刊有被预警的，想问下这个杂志质量怎么样，以后会不会被预警啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Jul 07 00:00:28 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111773, encodeId=15ea2111e73f5, content=偏重的研究方向：肿瘤 经验分享：2023.1.27 正月初六 submit , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Sat Jan 28 01:22:55 CST 2023, time=2023-01-28, status=1, ipAttribution=天津)]

2022-11-21 503616919

偏重的研究方向：肿瘤;基因功能
经验分享：11-16 投 11-21 replace消失期待外审

53 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117981, encodeId=f6a1211e981d8, content=2.8号投稿，审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Mon Mar 06 19:49:41 CST 2023, time=2023-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229420, encodeId=75dc1229420c9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：非编码RNA;上皮间质转化 经验分享：刚刚被拒。投稿3天后就送审了，还是周末状态改变的（按大家的经验应该是replace消失代表送审），等了刚好1个月的时候被拒的。理由是没找到审稿人，没有看到审稿人的意见。整体感觉编辑反应迅速的，可能IF涨了之后要求也高了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1ab5535030, createdName=简单93, createdTime=Wed Jun 29 11:17:57 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196851, encodeId=086c1196851a5, content=已经被预警了…现在在投的要撤稿吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJoHgeANyXDE4pHH8hREKNANRqlQhT0H9NBxJdM9icDDaq26HzcfpPWKn9wujOibbibULY65yuG4RWLg/132, createdBy=7b682217847, createdName=120f0027m97(暂无昵称), createdTime=Thu Feb 24 15:56:46 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090098, encodeId=56e62090098ac, content=请问这种情况Received 2022-9-23 from IP This manuscript is under review.但是replace没有消失的话是不是稿子还在编辑那儿没有送审啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14186510067, createdName=ms9000000493647933, createdTime=Sat Sep 24 11:45:31 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226665, encodeId=f04112266653b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础;肠道菌群 经验分享：发表一个月了，Web of science 核心数据库还检索不到，但是同卷的有的文章能检索到了，这是杂志问题还是Web of science库问题呀，开不了收录证明，好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99ea5615441, createdName=我们都是小白鼠, createdTime=Wed Jun 15 21:31:09 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205182, encodeId=a2961205182a4, content=Manuscript file和Cover letter文件后面的“replace”消失， Stats状态栏显示的是（active），然后显示的是Received 2022-3-9 from IP *.*.*.* This manuscript is under review. 请问这个状态代表的是已经送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed Mar 23 11:04:10 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996961, encodeId=ab889969615f, content=看这个杂志国人发文量差不多百分之九十，同一出版社的姊妹期刊有被预警的，想问下这个杂志质量怎么样，以后会不会被预警啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Jul 07 00:00:28 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111773, encodeId=15ea2111e73f5, content=偏重的研究方向：肿瘤 经验分享：2023.1.27 正月初六 submit , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Sat Jan 28 01:22:55 CST 2023, time=2023-01-28, status=1, ipAttribution=天津)]

2022-03-23 ms8000000802797021

Manuscript file和Cover letter文件后面的“replace”消失，
Stats状态栏显示的是（active），然后显示的是Received 2022-3-9 from IP *.*.*.* This manuscript is under review.

请问这个状态代表的是已经送外审了吗？

61 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117981, encodeId=f6a1211e981d8, content=2.8号投稿，审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Mon Mar 06 19:49:41 CST 2023, time=2023-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229420, encodeId=75dc1229420c9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：非编码RNA;上皮间质转化 经验分享：刚刚被拒。投稿3天后就送审了，还是周末状态改变的（按大家的经验应该是replace消失代表送审），等了刚好1个月的时候被拒的。理由是没找到审稿人，没有看到审稿人的意见。整体感觉编辑反应迅速的，可能IF涨了之后要求也高了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1ab5535030, createdName=简单93, createdTime=Wed Jun 29 11:17:57 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196851, encodeId=086c1196851a5, content=已经被预警了…现在在投的要撤稿吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJoHgeANyXDE4pHH8hREKNANRqlQhT0H9NBxJdM9icDDaq26HzcfpPWKn9wujOibbibULY65yuG4RWLg/132, createdBy=7b682217847, createdName=120f0027m97(暂无昵称), createdTime=Thu Feb 24 15:56:46 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090098, encodeId=56e62090098ac, content=请问这种情况Received 2022-9-23 from IP This manuscript is under review.但是replace没有消失的话是不是稿子还在编辑那儿没有送审啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14186510067, createdName=ms9000000493647933, createdTime=Sat Sep 24 11:45:31 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226665, encodeId=f04112266653b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础;肠道菌群 经验分享：发表一个月了，Web of science 核心数据库还检索不到，但是同卷的有的文章能检索到了，这是杂志问题还是Web of science库问题呀，开不了收录证明，好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99ea5615441, createdName=我们都是小白鼠, createdTime=Wed Jun 15 21:31:09 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205182, encodeId=a2961205182a4, content=Manuscript file和Cover letter文件后面的“replace”消失， Stats状态栏显示的是（active），然后显示的是Received 2022-3-9 from IP *.*.*.* This manuscript is under review. 请问这个状态代表的是已经送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed Mar 23 11:04:10 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996961, encodeId=ab889969615f, content=看这个杂志国人发文量差不多百分之九十，同一出版社的姊妹期刊有被预警的，想问下这个杂志质量怎么样，以后会不会被预警啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Jul 07 00:00:28 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111773, encodeId=15ea2111e73f5, content=偏重的研究方向：肿瘤 经验分享：2023.1.27 正月初六 submit , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Sat Jan 28 01:22:55 CST 2023, time=2023-01-28, status=1, ipAttribution=天津)]

2021-07-07 科研小麻瓜

看这个杂志国人发文量差不多百分之九十，同一出版社的姊妹期刊有被预警的，想问下这个杂志质量怎么样，以后会不会被预警啊？

132 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117981, encodeId=f6a1211e981d8, content=2.8号投稿，审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Mon Mar 06 19:49:41 CST 2023, time=2023-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229420, encodeId=75dc1229420c9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：非编码RNA;上皮间质转化 经验分享：刚刚被拒。投稿3天后就送审了，还是周末状态改变的（按大家的经验应该是replace消失代表送审），等了刚好1个月的时候被拒的。理由是没找到审稿人，没有看到审稿人的意见。整体感觉编辑反应迅速的，可能IF涨了之后要求也高了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1ab5535030, createdName=简单93, createdTime=Wed Jun 29 11:17:57 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196851, encodeId=086c1196851a5, content=已经被预警了…现在在投的要撤稿吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJoHgeANyXDE4pHH8hREKNANRqlQhT0H9NBxJdM9icDDaq26HzcfpPWKn9wujOibbibULY65yuG4RWLg/132, createdBy=7b682217847, createdName=120f0027m97(暂无昵称), createdTime=Thu Feb 24 15:56:46 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090098, encodeId=56e62090098ac, content=请问这种情况Received 2022-9-23 from IP This manuscript is under review.但是replace没有消失的话是不是稿子还在编辑那儿没有送审啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14186510067, createdName=ms9000000493647933, createdTime=Sat Sep 24 11:45:31 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226665, encodeId=f04112266653b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础;肠道菌群 经验分享：发表一个月了，Web of science 核心数据库还检索不到，但是同卷的有的文章能检索到了，这是杂志问题还是Web of science库问题呀，开不了收录证明，好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99ea5615441, createdName=我们都是小白鼠, createdTime=Wed Jun 15 21:31:09 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205182, encodeId=a2961205182a4, content=Manuscript file和Cover letter文件后面的“replace”消失， Stats状态栏显示的是（active），然后显示的是Received 2022-3-9 from IP *.*.*.* This manuscript is under review. 请问这个状态代表的是已经送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed Mar 23 11:04:10 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996961, encodeId=ab889969615f, content=看这个杂志国人发文量差不多百分之九十，同一出版社的姊妹期刊有被预警的，想问下这个杂志质量怎么样，以后会不会被预警啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Jul 07 00:00:28 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111773, encodeId=15ea2111e73f5, content=偏重的研究方向：肿瘤 经验分享：2023.1.27 正月初六 submit , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Sat Jan 28 01:22:55 CST 2023, time=2023-01-28, status=1, ipAttribution=天津)]

2022-02-23 悬崖听风007

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤免疫
经验分享：Received 2021-12-16 from IP
Minor revision 2022-2-8
Received 2022-2-17 from IP
Final accept 2022-2-22
Pre-publish-fee 2022-2-22
投稿到接受2个月零几天，效率杠杠的。感恩。

67 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117981, encodeId=f6a1211e981d8, content=2.8号投稿，审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Mon Mar 06 19:49:41 CST 2023, time=2023-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229420, encodeId=75dc1229420c9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：非编码RNA;上皮间质转化 经验分享：刚刚被拒。投稿3天后就送审了，还是周末状态改变的（按大家的经验应该是replace消失代表送审），等了刚好1个月的时候被拒的。理由是没找到审稿人，没有看到审稿人的意见。整体感觉编辑反应迅速的，可能IF涨了之后要求也高了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1ab5535030, createdName=简单93, createdTime=Wed Jun 29 11:17:57 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196851, encodeId=086c1196851a5, content=已经被预警了…现在在投的要撤稿吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJoHgeANyXDE4pHH8hREKNANRqlQhT0H9NBxJdM9icDDaq26HzcfpPWKn9wujOibbibULY65yuG4RWLg/132, createdBy=7b682217847, createdName=120f0027m97(暂无昵称), createdTime=Thu Feb 24 15:56:46 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090098, encodeId=56e62090098ac, content=请问这种情况Received 2022-9-23 from IP This manuscript is under review.但是replace没有消失的话是不是稿子还在编辑那儿没有送审啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14186510067, createdName=ms9000000493647933, createdTime=Sat Sep 24 11:45:31 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226665, encodeId=f04112266653b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础;肠道菌群 经验分享：发表一个月了，Web of science 核心数据库还检索不到，但是同卷的有的文章能检索到了，这是杂志问题还是Web of science库问题呀，开不了收录证明，好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99ea5615441, createdName=我们都是小白鼠, createdTime=Wed Jun 15 21:31:09 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205182, encodeId=a2961205182a4, content=Manuscript file和Cover letter文件后面的“replace”消失， Stats状态栏显示的是（active），然后显示的是Received 2022-3-9 from IP *.*.*.* This manuscript is under review. 请问这个状态代表的是已经送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed Mar 23 11:04:10 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996961, encodeId=ab889969615f, content=看这个杂志国人发文量差不多百分之九十，同一出版社的姊妹期刊有被预警的，想问下这个杂志质量怎么样，以后会不会被预警啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Jul 07 00:00:28 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111773, encodeId=15ea2111e73f5, content=偏重的研究方向：肿瘤 经验分享：2023.1.27 正月初六 submit , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Sat Jan 28 01:22:55 CST 2023, time=2023-01-28, status=1, ipAttribution=天津)]

2023-01-28 ms9000001669050818 来自天津

偏重的研究方向：肿瘤
经验分享：2023.1.27 正月初六 submit

36 11

展开11条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务